Patents

BioMS Medical receives additional patent for multiple sclerosis drug in U.S.

Published in Pharma Investments, Ventures and Law Weekly, December 10th, 2006

BioMS Medical Corp. (MS), a leading developer in the treatment of multiple sclerosis (MS), announced that the University of Alberta has received additional patents for the company's synthetic peptide therapeutic, MBP8298, for the treatment of multiple sclerosis (MS).

BioMS Medical licenses these patents on an exclusive worldwide basis from the University of Alberta.

The most recent patent, entitled "Methods of predicting therapeutic efficacy of treatment of a multiple sclerosis patient," has been granted in the United States and addresses methods of predicting efficacy of certain courses of treatment for MS patients.

"We are...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly

Source: Pharma Investments, Ventures and Law Weekly (2006-12-10)

More Articles from Pharma Investments, Ventures and Law Weekly

Business & Finance
Angiotech Pharmaceuticals reports income of $0.19 per share
Business & Finance
Connetics reports third quarter financial results
Business & Finance
Cross Country Healthcare reports $162.9 million for third quarter 2006
Business & Finance
Cutera reports 32% third-quarter revenue increase over same period last year
Business Update
China Medical Technologies and Chinese Academy of Sciences Institute of Acoustics form lab
Business Update
Drager Medical and Masimo announce expanded relationship
More from this issue of Pharma Investments, Ventures and Law Weekly

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry